RSV has been trending upwards since November before peaking on Dec. 21 with 2.7 hospitalizations per 100,000 people in the ...

GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...

For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.

Influenza A, COVID-19 and norovirus (stomach flu) are on the rise, according to the Centers for Disease Control and ...

Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...

The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...

The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, ...

RSV causes respiratory symptoms ranging from mild, cold-like discomfort to illnesses like bronchiolitis or pneumonia ...

Wisconsin DHS Respiratory Disease Epidemiologist Thomas Haupt told the Journal Sentinel in an email the department's most recent data indicates the state has "moderate RSV activity" but noted it is ...

The RSVpreF vaccine demonstrated 91% effectiveness against RSV-related lower respiratory tract disease in older adults during ...

More Americans believe in the effectiveness of vaccines developed to protect newborns and seniors against respiratory syncytial virus (RSV). More than half of U.S. adults (52%) think the RSV ...

Cases are climbing in China, but the situation is very different from when COVID-19 emerged five years ago, medical experts ...